Park West Asset Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-60,000
| Closed | -$4.92M | – | 46 |
|
|
2024
Q1 | $4.92M | Buy |
+60,000
| New | +$4.92M | 0.35% | 35 |
|
|
2022
Q3 | – | Sell |
-2,468,587
| Closed | -$7.13M | – | 67 |
|
|
2022
Q2 | $7.13M | Hold |
2,468,587
| – | – | 0.4% | 38 |
|
|
2022
Q1 | $7.41M | Buy |
2,468,587
+850,000
| +53% | +$2.55M | 0.26% | 53 |
|
|
2021
Q4 | $7.45M | Sell |
1,618,587
-50,000
| -3% | -$230K | 0.15% | 70 |
|
|
2021
Q3 | $10.5M | Hold |
1,668,587
| – | – | 0.25% | 69 |
|
|
2021
Q2 | $10M | Buy |
1,668,587
+70,600
| +4% | +$423K | 0.28% | 77 |
|
|
2021
Q1 | $10.1M | Buy |
1,597,987
+106,922
| +7% | +$676K | 0.31% | 77 |
|
|
2020
Q4 | $8.4M | Buy |
1,491,065
+33,558
| +2% | +$189K | 0.17% | 80 |
|
|
2020
Q3 | $8.48M | Hold |
1,457,507
| – | – | 0.33% | 66 |
|
|
2020
Q2 | $10.5M | Sell |
1,457,507
-140,000
| -9% | -$1.01M | 0.52% | 48 |
|
|
2020
Q1 | $7.48M | Buy |
1,597,507
+52,432
| +3% | +$245K | 0.51% | 45 |
|
|
2019
Q4 | $12.4M | Sell |
1,545,075
-202,432
| -12% | -$1.62M | 0.52% | 46 |
|
|
2019
Q3 | $12M | Hold |
1,747,507
| – | – | 0.59% | 41 |
|
|
2019
Q2 | $14.5M | Buy |
1,747,507
+175,000
| +11% | +$1.45M | 0.6% | 44 |
|
|
2019
Q1 | $15.6M | Sell |
1,572,507
-100,000
| -6% | -$994K | 0.69% | 38 |
|
|
2018
Q4 | $12.8M | Buy |
1,672,507
+403,400
| +32% | +$3.09M | 0.63% | 45 |
|
|
2018
Q3 | $22.1M | Buy |
1,269,107
+855,000
| +206% | +$14.9M | 0.81% | 35 |
|
|
2018
Q2 | $3.93M | Sell |
414,107
-85,893
| -17% | -$815K | 0.15% | 86 |
|
|
2018
Q1 | $2.19M | Sell |
500,000
-100,000
| -17% | -$437K | 0.1% | 78 |
|
|
2017
Q4 | $2.44M | Buy |
600,000
+400,000
| +200% | +$1.62M | 0.11% | 73 |
|
|
2017
Q3 | $382K | Hold |
200,000
| – | – | 0.02% | 67 |
|
|
2017
Q2 | $216K | Buy |
+200,000
| New | +$216K | 0.01% | 67 |
|